Market Overview

Robbins Arroyo LLP: Mednax, Inc. Accused of Misstating Sustainability of its Business Model in Recently Filed Class Action

Share:

Shareholder rights law firm Robbins
Arroyo LLP
announces that purchasers of Mednax, Inc. (NYSE:MD)
filed a class action complaint against the company's officers and
directors for alleged violations of the Securities Exchange Act of 1934
between February 4, 2016 and July 27, 2017. Mednax, Inc. is a health
care administration business that acquires and administers physician
practice groups.

View this information on the law firm's Shareholder Rights Blog: https://www.robbinsarroyo.com/mednax-inc-md/

Mednax, Inc. Accused of Making Misleading Statements

According to the complaint, during the class period Mednax touted the
sustainability of its business model, which depended upon growth from
the acquisition of new practice groups, primarily in anesthesiology. The
complaint alleges that in reality, the company's growth was based upon
suppressing physician compensation and enforcing non-compete agreements
to deter physician defections. On July 28, 2017, Mednax surprised the
market when it announced it had not acquired any anesthesiology practice
groups for that quarter and that the chance for acquiring any more was
remote. On this news, Mednax's stock declined by over 15%.

Mednax Shareholders Have Legal Options

If you would like more information about your rights and potential
remedies, contact attorney Leonid Kandinov at (800) 350-6003, LKandinov@robbinsarroyo.com,
or via the shareholder
information form
on the firm's website.

Robbins Arroyo LLP is a nationally recognized leader in shareholder
rights law. The firm represents individual and institutional investors
in shareholder derivative and securities class action lawsuits, and has
helped its clients realize more than $1 billion of value for themselves
and the companies in which they have invested. Sign up for our FREE
portfolio monitoring service, Stock
Watch
.

Attorney Advertising. Past results do not guarantee a similar outcome.

View Comments and Join the Discussion!